Cargando…

PT559. The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer’s Disease Subjects

Detalles Bibliográficos
Autores principales:	An, Hoyoung, Choi, Booyeol, Han, Seol-Heui, Hong, Chang Hyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616893/ http://dx.doi.org/10.1093/ijnp/pyw044.559

Ejemplares similares

PT585. Effect of Neuropsychiatric Symptoms on Mortality in Patients with Dementia: differences between Alzheimer’s dementia, subcortical vascular dementia, and frontotemporal dementia
por: Choi, Booyeol, et al.
Publicado: (2016)

Mild cognitive disorder and depression: treatment with combination of galantamine and escitalopram
por: Zarra, Julio, et al.
Publicado: (2010)

PT580. Alteration of neuronal nitric oxide synthase dimerization contributes to the development of Alzheimer’s disease
por: Kyoung, Ja Kwon, et al.
Publicado: (2016)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Depression in Acromegaly Treated with Escitalopram and Cognitive Therapy
por: De Sousa, Avinash
Publicado: (2009)

PT595. Incidence and course of depression in Alzheimer’s disease patients
por: Ryu, Seung-Ho, et al.
Publicado: (2016)

Mydriasis caused by ESCITALOPRAM: Case report
por: Bouattour, N., et al.
Publicado: (2022)

559. Efficacy and Tolerability of Integrase Inhibitors: Experiences From a Nationwide Real-Life Cohort
por: Lakatos, Botond, et al.
Publicado: (2018)

PT584. Peripheral inflammatory markers in Alzheimer’s disease and mild cognitive impairment
por: Kim, Yo Sup, et al.
Publicado: (2016)

PS176. A functional resonance imaging investigation of escitalopram monotherapy in first episode depression
por: Ravindran, Arun V., et al.
Publicado: (2016)

PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
por: Jeong, Jong-Hyun, et al.
Publicado: (2016)

PS108. Characteristics of escitalopram discontinuation syndrome
por: Norio-Furukori, Yasui, et al.
Publicado: (2016)

Mydriasis caused by ESCITALOPRAM: A case report
por: Bouattour, N., et al.
Publicado: (2023)

PS91. The effects of fluvoxamine on the steady-state plasma concentrations of escitalopram and desmethylescitalopram in depressed Japanese patients.
por: Kubo, Kazutoshi, et al.
Publicado: (2016)

559. A Nationwide Survey of COVID-19 Management in the Dominican Republic Over the Course of the Pandemic
por: Mena Lora, Alfredo J, et al.
Publicado: (2021)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Association between Plasma Metabolic Profiles of the Antidepressant Escitalopram and Clinical Response in Subjects with Depression
por: Bandu, Raju, et al.
Publicado: (2023)

559. Results of the implementation of a molecular pneumonia panel at a hospital in the Dominican Republic: expanding the scope of detection and management
por: Guzman-Marte, Anel E, et al.
Publicado: (2023)

PS99. First episode depression and monotherapy with escitalopram: A 16-week, open-label, flexible-dose study
por: Ravindran, Arun V., et al.
Publicado: (2016)

Efficacy of hyperbaric oxygen combined with escitalopram in depression and its effect on cognitive function
por: Mi, Kun, et al.
Publicado: (2021)

559. Outcomes of Convalescent Plasma Transfusion for SARS-CoV2 Patients in the Intensive Care Unit
por: Khalid, Rabeeya, et al.
Publicado: (2020)

PS209. Changes of cognitive function after escitalopram administration using single word-induced hemoglobin variation as an index
por: Shoji, Yoshihisa, et al.
Publicado: (2016)

559. Two Different Beasts: Comparing Epidemiology of Healthcare-Associated vs. Community-Acquired Methicillin-Resistant Staphylococcus aureus Bacteremia
por: McLaughlin, Luke, et al.
Publicado: (2019)

559 Risk Factors for Bronchial Asthma in Central Havana in the Period 1995–2010
por: Guerrero, Adelquis, et al.
Publicado: (2012)

Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
por: Shao, Shichuan, et al.
Publicado: (2022)

Increasing Burden of Alzheimer's Disease by Aging
por: Han, Seol-Heui
Publicado: (2014)

Role of central and peripheral neuropeptides in escitalopram-induced weight gain and metabolic changes
por: Yilmaz, M. Y.
Publicado: (2023)

THE EFFECT OF MOOD ON SELF-REPORTED COGNITION FOR INDIVIDUALS WITH HIV
por: Ertle, Emilee, et al.
Publicado: (2022)

PS179. A depressive patient who achieved remission by escitalopram: cerebral blood flow variation during pleasant/unpleasant image tasks.
por: Shoji, Yoshihisa, et al.
Publicado: (2016)

PS105. Effects of CYP2C19 genotype on steady-state plasma concentrations of escitalopram and desmetyl metabolite in Japanese depressed patients
por: Tsuchimine, Shoko, et al.
Publicado: (2016)

Comparative efficacy and safety of escitalopram, desvenlafaxine, and vortioxetine in the acute treatment of anxious depression: A randomized rater-blinded, 6-week clinical trial
por: Oh, K.-S., et al.
Publicado: (2022)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

Efficacy of escitalopram oxalate for patients with post-stroke depression
por: Xu, Ji-hua, et al.
Publicado: (2018)

Sexual functioning in females with depression in remission receiving escitalopram
por: Roy, Pritha, et al.
Publicado: (2019)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
por: Gammoh, Omar, et al.
Publicado: (2023)

GENETIC ARCHITECTURE OF SUBJECTIVE HEALTH: RELATIONSHIP WITH PHYSICAL HEALTH, COGNITION, AND DEPRESSION
por: Finkel, Deborah, et al.
Publicado: (2022)

Family history of mood disorders and concomitant psychopathology in patients with depression
por: Kasyanov, E., et al.
Publicado: (2021)

Comparing the Therapeutic Effects of Crocin, Escitalopram and Co-Administration of Escitalopram and Crocin on Learning and Memory in Rats with Stress-Induced Depression
por: Joodaki, Mehran, et al.
Publicado: (2021)

PT570. Apathy and Intrinsic Connectivity Networks in the Amnestic Mild Cognitive Impairment
por: Lee, Chang Uk, et al.
Publicado: (2016)

CYP2D6 P34S Polymorphism and Outcomes of Escitalopram Treatment in Koreans with Major Depression
por: Han, Kyu-Man, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2i9msqfs43rgri00732i75k1p6